Statistics on Biotechnology Use  
Results by fields of operation
Business Sector Biotechnology indicators by relevance of biotechnology to company activity.
Unidades: specified in variables

;Total;Main;Secondary dwellings;Tool;
Companies that carry out R&D in Biotechnology;1.348;661;188;500;
%Companies according to biotechnology used: Genetic code;31;40,3;25,2;21;
%Companies according to biotechnology used: Functional units;38,4;45,9;37,6;28,8;
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;21,7;27,3;15,9;16,5;
%Companies according to biotechnology used: Bioprocesses;50,3;40,9;53,3;61,7;
%Companies according to biotechnology used: Sub-cellular organisms;8,2;12,1;3,3;5;
%Companies according to biotechnology used: Bio-computing;24,1;33,8;20,2;12,9;
%Companies according to biotechnology used: Nanobiotechnology;11,8;15,9;14;5,4;
%Companies according to biotechnology used: Other;16,4;18,4;20,3;12,3;
%Company by field(s) of ultimate application of biotechnology use: Human Health;45,8;64,5;32,2;26,3;
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;15,3;17,2;14,5;12,9;
%Company by field(s) of ultimate application of biotechnology use: Food products;31,5;21,1;34,9;44,1;
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;23,7;19,9;32,9;25,2;
%Company by field(s) of ultimate application of biotechnology use: Environment;15,5;14,1;25,4;13,7;
%Company by field(s) of ultimate application of biotechnology use: Industry;13,4;14,3;19,1;10,1;
Personnel in R&D in biotechnology (no. of persons);15.744;8.573;1.786;5.385;
Personnel in R&D in biotechnology (no. of persons): Research personnel;8.380;5.028;952;2.400;
Personnel in R&D in biotechnology (no. of persons): Technical and auxiliary personnel;7.364;3.545;834;2.985;
Personnel in R&D in biotechnology (no. of persons). Women;8.725;4.985;952;2.788;
Personnel in R&D in biotechnology (no. of persons). Women: Research personnel;4.521;2.794;504;1.223;
Personnel in R&D in biotechnology (no. of persons). Women: Technical and auxiliary personnel;4.204;2.191;448;1.565;
Personnel in R&D in biotechnology (FTE);11.523,2;6.809,8;1.008,1;3.705,3;
Personnel in R&D in biotechnology (FTE): Research personnel;6.341,6;4.061,4;628,5;1.651,7;
Personnel in R&D in biotechnology (FTE): Technical and auxiliary personnel;5.181,6;2.748,4;379,7;2.053,6;
Personnel in R&D in biotechnology (FTE). Women;6.552,7;4.019,9;569,1;1.963,7;
Personnel in R&D in biotechnology (FTE). Women: Research personnel;3.464,4;2.258,6;349,8;855,9;
Personnel in R&D in biotechnology (FTE). Women: Technical and auxiliary personnel;3.088,3;1.761,3;219,3;1.107,7;
Internal expenditure on R&D (thousands of euros);1.037.887;643.053;81.049;313.785;
1) By nature of the expense: Current expenses;939.471;569.179;76.172;294.120;
1.1) Remuneration to research personnel;321.525;206.505;32.639;82.382;
1.2) Remuneration to technicians and auxiliary personnel;194.656;105.018;12.981;76.658;
1.3) Other current expenses;423.290;257.656;30.553;135.081;
2) By nature of the expense: Capital expenses;98.416;73.874;4.877;19.664;
2.1) Land and buildings;10.150;7.449;600;2.102;
2.2) Equipment and instruments;72.538;53.214;3.495;15.828;
2.3) Acquisition of specific R+D software;5.713;4.293;369;1.051;
2.4) Otros productos de propiedad intelectual específicos para I+D;10.015;8.918;413;684;
1.1) By origin of the funds: Own funds;711.037;412.945;55.579;242.513;
1.2) By origin of the funds: From companies;121.595;82.588;8.576;30.431;
1.3) By origin of the funds: Public Administration funds;107.422;66.483;11.401;29.539;
1.4) By origin of the funds: From Universities;192;68;14;111;
1.5) By origin of the funds: From non profit private institutions;10.756;9.444;0;1.312;
1.6) By origin of the funds: Foreign funds;86.884;71.524;5.480;9.880;
Purchase of R&D services in biotechnology (thousands of euros);145.440;107.282;14.145;24.013;
Purchase of R&D services in biotechnology (thousands of euros): In Spain;95.870;75.671;12.772;7.428;
Purchase of R&D services in biotechnology (thousands of euros): Abroad;49.570;31.611;1.374;16.585;
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;39,8;48,6;37,5;28,9;
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;12,5;11,4;15,6;12,7;
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;18,5;20,9;20,6;14,4;
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;11,2;10,5;15,2;10,7;
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;15,6;16;25,4;11,3;
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels;16,5;19;21,4;11,5;
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;16,1;16,4;23,8;12,7;
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;40;47,3;42,8;29,4;
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost;53,9;62,7;54,5;41,9;
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;21,5;23,6;26,1;16,9;
% Companies with income of an international origin related to biotechnological activities;22,2;29,9;15,4;14,7;
% Turnover representing income of an international origin related to biotechnological activities;1,9;13,4;0,1;1,5;
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU;65,5;67,7;57;60,1;
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries;34,5;32,3;43;39,9;
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services;86,3;82,7;91,3;96,5;
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;12,2;16,4;1,2;0,9;
% Income of an international origin related with activities according to the classification: Operating source abroad;1,1;0,8;7,5;1,3;
% Income of an international origin related with activities according to the classification: Other;0,4;0,1;0;1,3;
Notas:
'.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Fuente: National Statistics Institute